Guangzhou Baiy | 600332 - Cost Of Sales

Stock Price
25.61
Daily Change
0.06 0.23%
Monthly
0.67%
Yearly
-5.60%
Q1 Forecast
24.69

Guangzhou Baiy reported CNY16.58B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Aspen Pharmacare ZAR 12.73B 1.22B Jun/2025
Cipla INR 29.1B 1.16B Dec/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Jiangsu Hengrui CNY 1.08B 34.18M Sep/2025
Kalbe Farma IDR 5.46T 523.94B Sep/2025
Richter Gedeon HUF 71.32B 2.26B Sep/2025
Sh Fosun Pharma CNY 5.08B 121.44M Sep/2025
Sh Pharmaceutical CNY 65.99B 2.84B Sep/2025
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025